Clinical outcomes and prognostic factors in patients with mycosis fungoides who underwent radiation therapy in a single institution
- Author:
Bum Sup JANG
1
;
Eunji KIM
;
Il Han KIM
;
Hyun Cheol KANG
;
Sung Joon YE
Author Information
- Publication Type:Original Article
- Keywords: Mycosis fungoides; Radiotherapy; Total skin electron beam radiotherapy; Cutaneous T-cell lymphoma; Total skin electron irradiation
- MeSH: Diagnosis; Disease-Free Survival; Humans; Lymph Nodes; Lymphoma, T-Cell, Cutaneous; Multivariate Analysis; Mycosis Fungoides; Radiotherapy; Retrospective Studies; Skin
- From:Radiation Oncology Journal 2018;36(2):153-162
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: We aimed to evaluate clinical outcomes including progression-free survival (PFS), overall survival (OS), partial response, and complete response in patients who underwent radiation therapy (RT) for mycosis fungoides (MF). Also, we sought to find prognostic factors for clinical outcomes. MATERIALS AND METHODS: Total 19 patients confirmed with MF between 1999–2015 were retrospectively reviewed. Clinical and treatment characteristics, clinical outcomes, and and toxicities were analyzed. RESULTS: Eleven patients were treated with total skin electron beam radiotherapy (TSEBT) and 8 patients with involved field radiation therapy (IFRT) with median dose of 30 Gy, respectively. The median time interval from diagnosis to RT was 2.6 months (range, 0.4 to 87.3 months). The overall response rate was 100%; 11 patients (57.9%) had a complete response and 8 patients (42.1%) a partial response. The presence of positive lymph node at the time of consultation of RT was associated with lower OS (p = 0.043). In multivariate analysis, PFS was significantly lower for patients with increased previous therapies experienced following RT (p = 0.019) and for patients showing PR during RT (p = 0.044). There were no reported grade 3 or more skin toxicities related with RT. CONCLUSION: Both IFRT and TSEBT are effective treatment for MF patients. Patients with short disease course before RT or complete response during RT are expected to have longer PFS. Positive lymph node status at the initiation of RT was associated woth poor OS, suggesting other treatment modalities such as low-dose RT for patients with low life-expectancy.
